Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Ocellaris Pharma, Inc.
University of Virginia
Kymab Limited
Cellestia Biotech AG
Atreca, Inc.
Fate Therapeutics
Gossamer Bio Inc.
Eli Lilly and Company
Incyte Corporation
Effector Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AbbVie
Cornerstone Pharmaceuticals